EUROPE BIOTECHNOLOGY REAGENTS MARKET FORECAST 2020-2028

  • You are here:
  • Home
  • Reports
  • EUROPE BIOTECHNOLOGY REAGENTS MARKET FORECAST 2020-2028

EUROPE BIOTECHNOLOGY REAGENTS MARKET FORECAST 2020-2028

The European biotechnology reagents market is evaluated to reach a CAGR of 6.13% during the projected period, 2020-2028. The increasing healthcare expenditure and rising number of healthcare biotechnology-based companies in Europe are the dominating factors of market growth in Europe. The biotechnology reagents market of Europe is divided into countries such as the United Kingdom, France, Germany, Italy, Russia, Belgium, Poland, and the Rest of Europe, for further evaluation. The growth of the UK market is attributed to the growing geriatric population, increasing chronic diseases like diabetes, Parkinson’s disease, etc. and increasing demand for personalized medicines, which further helps to surge the consumption of biotechnology reagents in clinical trials and testing. In countries like France, the initiatives taken by the government for the healthcare sector have become the major factor for the growth of the French biotechnology reagents market.

EUROPE BIOTECHNOLOGY REAGENTS MARKET FORECAST 2020-2028

Europe Biotechnology Reagents Market by Application (Protein Synthesis & Purification, Gene Expression, DNA & RNA Analysis, Drug Testing) by Technology (Life Science Reagents, Analytical Reagents) by Geography.

Request free sample

The European biotechnology reagents market is evaluated to reach a CAGR of 6.13% during the projected period, 2020-2028. The increasing healthcare expenditure and rising number of healthcare biotechnology-based companies in Europe are the dominating factors of market growth in Europe.

To know more about this report, request a free sample copy.

The biotechnology reagents market of Europe is divided into countries such as the United Kingdom, France, Germany, Italy, Russia, Belgium, Poland, and the Rest of Europe, for further evaluation. The growth of the UK market is attributed to the growing geriatric population, increasing chronic diseases like diabetes, Parkinson’s disease, etc. and increasing demand for personalized medicines, which further helps to surge the consumption of biotechnology reagents in clinical trials and testing. In countries like France, the initiatives taken by the government for the healthcare sector have become the major factor for the growth of the French biotechnology reagents market. The aging population and the prevalence of chronic disorders like dementia (Alzheimer’s), cardiovascular diseases, etc. is another major factor for market growth in France. In Germany, the increasing healthcare expenditure and the rise in the geriatric population with chronic diseases like asthma, diabetes, etc. are the key factors leading to market growth. The upsurge in the investments in the pharmaceutical and biotechnology industries and the increasing population of old people lead to the growth of the Italian biotechnology reagents market.

Lonza Group Ltd, with its headquarter in Basel, Switzerland, operates manufacturing and research and development facilities across Europe, Asia, and America.

 

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    • MARKET DRIVERS
      • LARGE INVESTMENT IN BIOTECHNOLOGY BY THE CORPORATES AND RESEARCH ORGANIZATIONS
      • EVOLVING LANDSCAPE OF THE BIOTECHNOLOGY INDUSTRY
      • INCREASING PROTEIN PROFILING APPLICATIONS
    • MARKET RESTRAINTS
      • HIGH COST OF BIOPHARMACEUTICAL RESEARCH AND DRUG DEVELOPMENT
      • CONTAMINATION ISSUES
      • REGULATORY DIFFERENCE IN VARIOUS COUNTRIES
  1. KEY ANALYTICS
    • PORTER’S FIVE FORCE ANALYSIS
      • NEW ENTRANTS
      • SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • INDUSTRY RIVALRY
    • KEY BUYING CRITERIA
      • SUSTAINABILITY
      • QUALITY OF PRODUCT
      • COST
      • AVAILABILITY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY APPLICATION
    • PROTEIN SYNTHESIS & PURIFICATION
    • GENE EXPRESSION
    • DNA & RNA ANALYSIS
    • DRUG TESTING
  3. MARKET BY TECHNOLOGY
    • LIFE SCIENCE REAGENTS
      • PCR
        • MASTER MIXES
        • PCR REAGENT KIT
      • CELL CULTURE
        • SERA
        • MEDIA AND REAGENTS
      • INVITRO DIAGNOSTIC
      • EXPRESSION AND TRANSFECTION
    • ANALYTICAL REAGENTS
      • CHROMATOGRAPHY
      • MASS SPECTROMETRY
      • ELECTROPHORESIS
      • FLOW CYTOMETRY
  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. COMPANY PROFILES
    • ABBOTT LABORATORIES
    • AGILENT TECHNOLOGIES INC.
    • BECTON, DICKINSON & COMPANY (BD)
    • BIO-RAD LABORATORIES INC.
    • BIO-TECHNE CORPORATION
    • CORNING INC.
    • GE HEALTHCARE
    • INVIVOSCRIBE TECHNOLOGIES INC
    • LONZA GROUP LTD.
    • MERCK KGAA
    • MERIDIAN BIOSCIENCE INC
    • PERKINELMER
    • PROMOCELL GMBH
    • SIGNALCHEM LIFESCIENCES CORPORATION
    • VWR CORPORATION (PART OF AVANTOR)

 

TABLE LIST

TABLE 1: BIOTECHNOLOGY REAGENTS MARKET AT A GLANCE/MARKET SNAPSHOT/MARKET SUMMARY

TABLE 2: EUROPE BIOTECHNOLOGY REAGENTS, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: EUROPE BIOTECHNOLOGY REAGENTS, BY APPLICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 4: EUROPE PROTEIN SYNTHESIS & PURIFICATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: EUROPE PROTEIN SYNTHESIS & PURIFICATION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 6: EUROPE GENE EXPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: EUROPE GENE EXPRESSION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 8: EUROPE DNA & RNA ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: EUROPE DNA & RNA ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 10: EUROPE DRUG TESTING MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 11: EUROPE DRUG TESTING MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 12: EUROPE BIOTECHNOLOGY REAGENTS, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 13: EUROPE BIOTECHNOLOGY REAGENTS, BY TECHNOLOGY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 14: EUROPE LIFE SCIENCE REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 15: EUROPE LIFE SCIENCE REAGENTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 16: EUROPE LIFE SCIENCE REAGENTS MARKET, BY TYPE HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 17: EUROPE LIFE SCIENCE REAGENTS MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 18: EUROPE PCR MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 19: EUROPE PCR MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 20: EUROPE PCR MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 21: EUROPE PCR MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 22: EUROPE MASTER MIXES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 23: EUROPE MASTER MIXES MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 24: EUROPE PCR REAGENT KIT MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 25: EUROPE PCR REAGENT KIT MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 26: EUROPE CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 27: EUROPE CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 28: EUROPE CELL CULTURE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 29: EUROPE CELL CULTURE MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 30: EUROPE SERA MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 31: EUROPE SERA MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 32: EUROPE MEDIA AND REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 33: EUROPE MEDIA AND REAGENTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 34: EUROPE INVITRO DIAGNOSTIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 35: EUROPE INVITRO DIAGNOSTIC MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 36: EUROPE EXPRESSION AND TRANSFECTION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 37: EUROPE EXPRESSION AND TRANSFECTION MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 38: EUROPE ANALYTICAL REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 39: EUROPE ANALYTICAL REAGENTS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 40: EUROPE ANALYTICAL REAGENTS MARKET, BY TYPE HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 41: EUROPE ANALYTICAL REAGENTS MARKET, BY TYPE, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 42: EUROPE CHROMATOGRAPHY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 43: EUROPE CHROMATOGRAPHY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 44: EUROPE MASS SPECTROMETRY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 45: EUROPE MASS SPECTROMETRY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 46: EUROPE ELECTROPHORESIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 47: EUROPE ELECTROPHORESIS MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 48: EUROPE FLOW CYTOMETRY MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 49: EUROPE FLOW CYTOMETRY MARKET, BY REGION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 50: EUROPE BIOTECHNOLOGY REAGENTS, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 51: EUROPE BIOTECHNOLOGY REAGENTS, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

FIGURES LIST

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: KEY BUYING CRITERIA

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: VENDOR LANDSCAPE OF BIOTECHNOLOGY REAGENTS MARKET

FIGURE 5: EUROPE BIOTECHNOLOGY REAGENTS MARKET GROWTH POTENTIAL, BY APPLICATION, 2019

FIGURE 6: EUROPE BIOTECHNOLOGY REAGENTS MARKET, BY PROTEIN SYNTHESIS & PURIFICATION, 2020-2028 (IN $ MILLION)

FIGURE 7: EUROPE BIOTECHNOLOGY REAGENTS MARKET, BY GENE EXPRESSION, 2020-2028 (IN $ MILLION)

FIGURE 8: EUROPE BIOTECHNOLOGY REAGENTS MARKET, BY DNA & RNA ANALYSIS, 2020-2028 (IN $ MILLION)

FIGURE 9: EUROPE BIOTECHNOLOGY REAGENTS MARKET, BY DRUG TESTING, 2020-2028 (IN $ MILLION)

FIGURE 10: EUROPE BIOTECHNOLOGY REAGENTS MARKET GROWTH POTENTIAL, BY TECHNOLOGY, 2019

FIGURE 11: EUROPE BIOTECHNOLOGY REAGENTS MARKET, BY LIFE SCIENCE REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 12: EUROPE LIFE SCIENCE REAGENTS MARKET, BY PCR, 2020-2028 (IN $ MILLION)

FIGURE 13: EUROPE PCR MARKET, BY MASTER MIXES, 2020-2028 (IN $ MILLION)

FIGURE 14: EUROPE PCR MARKET, BY PCR REAGENT KIT, 2020-2028 (IN $ MILLION)

FIGURE 15: EUROPE LIFE SCIENCE REAGENTS MARKET, BY CELL CULTURE, 2020-2028 (IN $ MILLION)

FIGURE 16: USE OF ANIMAL SERUM MEDIA IN THE STUDY OF MESENCHYMAL STROMAL CELLS IN CELL CULTURE

FIGURE 17: EUROPE CELL CULTURE MARKET, BY SERA, 2020-2028 (IN $ MILLION)

FIGURE 18: EUROPE CELL CULTURE MARKET, BY MEDIA AND REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 19: EUROPE LIFE SCIENCE REAGENTS MARKET, BY INVITRO DIAGNOSTIC, 2020-2028 (IN $ MILLION)

FIGURE 20: EUROPE LIFE SCIENCE REAGENTS MARKET, BY EXPRESSION AND TRANSFECTION, 2020-2028 (IN $ MILLION)

FIGURE 21: EUROPE BIOTECHNOLOGY REAGENTS MARKET, BY ANALYTICAL REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 22: EUROPE ANALYTICAL REAGENTS MARKET, BY CHROMATOGRAPHY, 2020-2028 (IN $ MILLION)

FIGURE 23: EUROPE ANALYTICAL REAGENTS MARKET, BY MASS SPECTROMETRY, 2020-2028 (IN $ MILLION)

FIGURE 24: EUROPE ANALYTICAL REAGENTS MARKET, BY ELECTROPHORESIS, 2020-2028 (IN $ MILLION)

FIGURE 25: EUROPE ANALYTICAL REAGENTS MARKET, BY FLOW CYTOMETRY, 2020-2028 (IN $ MILLION)

FIGURE 26: EUROPE BIOTECHNOLOGY REAGENTS MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 27: THE UNITED KINGDOM BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 28: FRANCE BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 29: GERMANY BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 30: BIOTECHNOLOGY APPLICATIONS IN GERMANY

FIGURE 31: ITALY BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 32: RUSSIA BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 33: BELGIUM BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 34: POLAND BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)

FIGURE 35: REST OF EUROPE BIOTECHNOLOGY REAGENTS, 2020-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    • EUROPE
      • THE UNITED KINGDOM
      • FRANCE
      • GERMANY
      • ITALY
      • RUSSIA
      • BELGIUM
      • POLAND
      • REST OF EUROPE
  1. MARKET BY APPLICATION
    • PROTEIN SYNTHESIS & PURIFICATION
    • GENE EXPRESSION
    • DNA & RNA ANALYSIS
    • DRUG TESTING
  2. MARKET BY TECHNOLOGY
    • LIFE SCIENCE REAGENTS
      • PCR
        • MASTER MIXES
        • PCR REAGENT KIT
      • CELL CULTURE
        • SERA
        • MEDIA AND REAGENTS
      • INVITRO DIAGNOSTIC
      • EXPRESSION AND TRANSFECTION
    • ANALYTICAL REAGENTS
      • CHROMATOGRAPHY
      • MASS SPECTROMETRY
      • ELECTROPHORESIS
      • FLOW CYTOMETRY

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now